Collective Resistance in Microbial Communities by Intracellular Antibiotic Deactivation

PLoS Biology

Volumn 14, Issue 12, 2016, Pages

  Sorg, Robin A ^a   Lin, Leo ^b   van Doorn, G Sander ^c   Sorg, Moritz ^a   Olson, Joshua ^b   Nizet, Victor ^b,d   Veening, Jan Willem ^a,e  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF GRONINGEN   (Netherlands)

^d UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^e UNIVERSITY OF LAUSANNE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; CHLORAMPHENICOL ACETYLTRANSFERASE; ANTIINFECTIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL GROWTH; BACTERIAL SURVIVAL; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; IN VIVO STUDY; MATHEMATICAL MODEL; MICROBIAL COMMUNITY; MOUSE; NONHUMAN; PROTEIN EXPRESSION; STREPTOCOCCUS PNEUMONIA; STREPTOCOCCUS PNEUMONIAE; DRUG EFFECTS;

ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, MICROBIAL; STREPTOCOCCUS PNEUMONIAE;

EID: 85009110206     PISSN: 15449173     EISSN: 15457885     Source Type: Journal    
DOI: 10.1371/journal.pbio.2000631     Document Type: Article

References (56)

1. World Health Organization. Antimicrobial resistance: global report on surveillance. 2014 http://www.who.int/drugresistance/documents/surveillancereport/en.
2. Vega NM, Gore J, Collective antibiotic resistance: mechanisms and implications. Curr Opin Microbiol. 2014Oct;21C:28–34.
3. Levin BR, Rozen DE, Non-inherited antibiotic resistance. Nat Rev Microbiol. 2006Jul;4(7):556–62. doi: 10.1038/nrmicro144516778840
4. Chi DH, Hendley JO, French P, Arango P, Hayden FG, Winther B, Nasopharyngeal reservoir of bacterial otitis media and sinusitis pathogens in adults during wellness and viral respiratory illness. Am J Rhinol. 2003Aug;17(4):209–14. 12962190
5. Allen EK, Koeppel AF, Hendley JO, Turner SD, Winther B, Sale MM, Characterization of the nasopharyngeal microbiota in health and during rhinovirus challenge. Microbiome. 2014Jun25;2(1):22.
6. Teo SM, Mok D, Pham K, Kusel M, Serralha M, Troy N, et al. The infant nasopharyngeal microbiome impacts severity of lower respiratory infection and risk of asthma development. Cell Host Microbe. 2015May13;17(5):704–15. doi: 10.1016/j.chom.2015.03.00825865368
7. Kirby AE, Garner K, Levin BR, The relative contributions of physical structure and cell density to the antibiotic susceptibility of bacteria in biofilms. Antimicrob Agents Chemother. 2012Jun;56(6):2967–75. doi: 10.1128/AAC.06480-1122450987
8. Lebeaux D, Ghigo J-M, Beloin C, Biofilm-related infections: bridging the gap between clinical management and fundamental aspects of recalcitrance toward antibiotics. Microbiol Mol Biol Rev MMBR. 2014Sep;78(3):510–43. doi: 10.1128/MMBR.00013-1425184564
9. Ackermann M, A functional perspective on phenotypic heterogeneity in microorganisms. Nat Rev Microbiol. 2015Aug;13(8):497–508. doi: 10.1038/nrmicro349126145732
10. Tuomanen E, Cozens R, Tosch W, Zak O, Tomasz A, The rate of killing of Escherichia coli by beta-lactam antibiotics is strictly proportional to the rate of bacterial growth. J Gen Microbiol. 1986May;132(5):1297–304. doi: 10.1099/00221287-132-5-12973534137
11. Eng RH, Padberg FT, Smith SM, Tan EN, Cherubin CE, Bactericidal effects of antibiotics on slowly growing and nongrowing bacteria. Antimicrob Agents Chemother. 1991Sep1;35(9):1824–8. 1952852
12. Sorg RA, Veening J-W, Microscale insights into pneumococcal antibiotic mutant selection windows. Nat Commun. 2015;6:8773. doi: 10.1038/ncomms977326514094
13. Balaban NQ, Merrin J, Chait R, Kowalik L, Leibler S, Bacterial persistence as a phenotypic switch. Science. 2004Sep10;305(5690):1622–5. doi: 10.1126/science.109939015308767
14. Gerdes K, Maisonneuve E, Bacterial persistence and toxin-antitoxin loci. Annu Rev Microbiol. 2012;66:103–23. doi: 10.1146/annurev-micro-092611-15015922994490
15. Prudhomme M, Attaiech L, Sanchez G, Martin B, Claverys J-P, Antibiotic stress induces genetic transformability in the human pathogen Streptococcus pneumoniae. Science. 2006Jul7;313(5783):89–92. doi: 10.1126/science.112791216825569
16. Stevens KE, Chang D, Zwack EE, Sebert ME, Competence in Streptococcus pneumoniae is regulated by the rate of ribosomal decoding errors. mBio. 2011;2(5).
17. Slager J, Kjos M, Attaiech L, Veening J-W, Antibiotic-induced replication stress triggers bacterial competence by increasing gene dosage near the origin. Cell. 2014Apr10;157(2):395–406. doi: 10.1016/j.cell.2014.01.06824725406
18. Lee HH, Molla MN, Cantor CR, Collins JJ, Bacterial charity work leads to population-wide resistance. Nature. 2010Sep2;467(7311):82–5. doi: 10.1038/nature0935420811456
19. Brook I, Inoculum effect. Rev Infect Dis. 1989May1;11(3):361–8. 2664999
20. Dugatkin LA, Perlin M, Lucas JS, Atlas R, Group-beneficial traits, frequency-dependent selection and genotypic diversity: an antibiotic resistance paradigm. Proc Biol Sci. 2005Jan7;272(1558):79–83. doi: 10.1098/rspb.2004.291615875573
21. Yurtsev EA, Chao HX, Datta MS, Artemova T, Gore J, Bacterial cheating drives the population dynamics of cooperative antibiotic resistance plasmids. Mol Syst Biol. 2013;9:683. doi: 10.1038/msb.2013.3923917989
22. Medaney F, Dimitriu T, Ellis RJ, Raymond B, Live to cheat another day: bacterial dormancy facilitates the social exploitation of β-lactamases. ISME J. 2016Mar;10(3):778–87. doi: 10.1038/ismej.2015.15426505830
23. Brook I, The role of beta-lactamase-producing bacteria in the persistence of streptococcal tonsillar infection. Rev Infect Dis. 1984Oct;6(5):601–7. 6390637
24. Weimer KED, Juneau RA, Murrah KA, Pang B, Armbruster CE, Richardson SH, et al. Divergent mechanisms for passive pneumococcal resistance to β-lactam antibiotics in the presence of Haemophilus influenzae. J Infect Dis. 2011Feb15;203(4):549–55. doi: 10.1093/infdis/jiq08721220774
25. Brook I, The role of beta-lactamase-producing-bacteria in mixed infections. BMC Infect Dis. 2009;9:202. doi: 10.1186/1471-2334-9-20220003454
26. Shaw WV, The enzymatic acetylation of chloramphenicol by extracts of R factor-resistant Escherichia coli. J Biol Chem. 1967Feb25;242(4):687–93. 5335032
27. Suzuki Y, Okamoto S, The enzymatic acetylation of chloramphenicol by the multiple drug-resistant Escherichia coli carrying R factor. J Biol Chem. 1967Oct25;242(20):4722–30. 4964809
28. Shaw WV, Unowsky J, Mechanism of R factor-mediated chloramphenicol resistance. J Bacteriol. 1968May;95(5):1976–8. 4870290
29. Nicoloff H, Andersson DI, Indirect resistance to several classes of antibiotics in cocultures with resistant bacteria expressing antibiotic-modifying or -degrading enzymes. J Antimicrob Chemother. 2016Jan;71(1):100–10. doi: 10.1093/jac/dkv31226467993
30. Yurtsev EA, Conwill A, Gore J, Oscillatory dynamics in a bacterial cross-protection mutualism. Proc Natl Acad Sci U S A. 2016May31;113(22):6236–41. doi: 10.1073/pnas.152331711327194723
31. Tomasz A, Antibiotic resistance in Streptococcus pneumoniae. Clin Infect Dis. 1997Jan1;24(Supplement 1):S85–8.
32. Lewis K, Platforms for antibiotic discovery. Nat Rev Drug Discov. 2013May;12(5):371–87. doi: 10.1038/nrd397523629505
33. Chewapreecha C, Harris SR, Croucher NJ, Turner C, Marttinen P, Cheng L, et al. Dense genomic sampling identifies highways of pneumococcal recombination. Nat Genet. 2014Mar;46(3):305–9. doi: 10.1038/ng.289524509479
34. World Health Organization. Model list of essential medicines. 2015 http://www.who.int/selection_medicines/committees/expert/20/EML_2015_FINAL_amended_AUG2015.pdf?ua=1.
35. Falagas ME, Grammatikos AP, Michalopoulos A, Potential of old-generation antibiotics to address current need for new antibiotics. Expert Rev Anti Infect Ther. 2008Oct;6(5):593–600. doi: 10.1586/14787210.6.5.59318847400
36. Maviglia R, Nestorini R, Pennisi M, Role of old antibiotics in multidrug resistant bacterial infections. Curr Drug Targets. 2009Sep;10(9):895–905. 19799544
37. Nitzan O, Suponitzky U, Kennes Y, Chazan B, Raul R, Colodner R, Is chloramphenicol making a comeback?Isr Med Assoc J IMAJ. 2010Jun;12(6):371–4. 20928993
38. Avery OT, Macleod CM, McCarty M, Studies on the chemical nature of the substance inducing transformation of pneumococcal types: induction of transformation by a desoxyribonucleic acid fraction isolated from pneumococcus type III. J Exp Med. 1944Feb1;79(2):137–58. 19871359
39. Robins-Brown RM, Gaspar MN, Ward JI, Wachsmuth IK, Koornhof HJ, Jacobs MR, et al. Resistance mechanisms of multiply resistant pneumococci: antibiotic degradation studies. Antimicrob Agents Chemother. 1979Mar;15(3):470–4. 37802
40. Taber HW, Mueller JP, Miller PF, Arrow AS, Bacterial uptake of aminoglycoside antibiotics. Microbiol Rev. 1987Dec;51(4):439–57. 3325794
41. Sorg RA, Kuipers OP, Veening J-W, Gene expression platform for synthetic biology in the human pathogen Streptococcus pneumoniae. ACS Synth Biol. 2015Mar20;4(3):228–39. doi: 10.1021/sb500229s24845455
42. Ballester S, Lopez P, Alonso JC, Espinosa M, Lacks SA, Selective advantage of deletions enhancing chloramphenicol acetyltransferase gene expression in Streptococcus pneumoniae plasmids. Gene. 1986;41(2–3):153–63. 3011593
43. Feder HM, Chloramphenicol: what we have learned in the last decade. South Med J. 1986Sep;79(9):1129–34. 3529436
44. Branca C, Ricci A, Torelli A, Amorosi S, Gaetani E, Laureri CF, et al. Non-radioactive detection of β-glucuronidase and chloramphenicol acetyltransferase activities in co-transformed protoplasts by HPLC. Plant Cell Rep. 1993May;12(7–8):361–5. doi: 10.1007/BF0023469324197333
45. Hardin G, The competitive exclusion principle. Science. 1960Apr29;131(3409):1292–7. 14399717
46. Kristian SA, Timmer AM, Liu GY, Lauth X, Sal-Man N, Rosenfeld Y, et al. Impairment of innate immune killing mechanisms by bacteriostatic antibiotics. FASEB J Off Publ Fed Am Soc Exp Biol. 2007Apr;21(4):1107–16.
47. Hu Y, Yang X, Qin J, Lu N, Cheng G, Wu N, et al. Metagenome-wide analysis of antibiotic resistance genes in a large cohort of human gut microbiota. Nat Commun. 2013;4:2151. doi: 10.1038/ncomms315123877117
48. van Schaik W, The human gut resistome. Philos Trans R Soc Lond B Biol Sci. 2015Jun5;370(1670):20140087. doi: 10.1098/rstb.2014.008725918444
49. Moore AM, Ahmadi S, Patel S, Gibson MK, Wang B, Ndao MI, et al. Gut resistome development in healthy twin pairs in the first year of life. Microbiome. 2015;3:27. doi: 10.1186/s40168-015-0090-926113976
50. Van Boeckel TP, Gandra S, Ashok A, Caudron Q, Grenfell BT, Levin SA, et al. Global antibiotic consumption 2000 to 2010: an analysis of national pharmaceutical sales data. Lancet Infect Dis. 2014Aug;14(8):742–50. doi: 10.1016/S1473-3099(14)70780-725022435
51. Robicsek A, Strahilevitz J, Jacoby GA, Macielag M, Abbanat D, Park CH, et al. Fluoroquinolone-modifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med. 2006Jan;12(1):83–8. doi: 10.1038/nm134716369542
52. Halfmann A, Hakenbeck R, Brückner R, A new integrative reporter plasmid for Streptococcus pneumoniae. FEMS Microbiol Lett. 2007Mar;268(2):217–24. doi: 10.1111/j.1574-6968.2006.00584.x17328748
53. Prudhomme M, Claverys J-P, There will be a light: the use of luc transcriptional fusions in living pneumococcal cells. In “The Molecular Biology of Streptococci.” Horizon Scientific Press; 2007. pp. 519–524
54. Pang YY, Schwartz J, Thoendel M, Ackermann LW, Horswill AR, Nauseef WM, agr-Dependent interactions of Staphylococcus aureus USA300 with human polymorphonuclear neutrophils. J Innate Immun. 2010;2(6):546–59. doi: 10.1159/00031985520829608
55. Bergé M, Moscoso M, Prudhomme M, Martin B, Claverys J-P, Uptake of transforming DNA in Gram-positive bacteria: a view from Streptococcus pneumoniae. Mol Microbiol. 2002Jul;45(2):411–21. 12123453
56. Revelli DA, Boylan JA, Gherardini FC, A non-invasive intratracheal inoculation method for the study of pulmonary melioidosis. Front Cell Infect Microbiol. 2012;2:164. doi: 10.3389/fcimb.2012.0016423267442